Hyponatremia associates with poor outcome in metastatic renal cell carcinoma patients treated with everolimus: prognostic impact
Open Access
- 4 June 2018
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 57 (11) , 1580-1585
Abstract
Background: The prognostication of metastatic renal cell carcinoma (mRCC) is based on Memorial Sloan Kettering Cancer Center (MSKCC) and International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk classifications. Research has shown that hyponatremia is associated with worse prognosis in cancer. We analyzed the association of hyponatremia and outcome in everolimus-treated mRCC patients. Patients and methods: Baseline and on-treatment (≤12 weeks) sodium in 233 mRCC patients was analyzed using Kaplan–Meier, Cox regression and logistic regression. Baseline sodium was correlated with baseline thrombocyte and neutrophil values. Results: 65 (28%) and 41 (18%) patients had sodium < lower limit of normal (LLN) at baseline and on-treatment, respectively. Baseline sodium < LLN was associated with shorter overall survival (OS) (6.1 vs. 10.3 months; p < .001) and progression-free survival (PFS) (2.8 vs. 3.5 months; p = .04). On-treatment sodium < LLN was associated with shorter OS (5.4 vs. 9.9 months; p < .001) and PFS (2.8 vs. 4.0 months; p < .001). In multivariate analyses adjusted for IMDC factors, baseline and on-treatment sodium < LLN were significantly associated with shorter OS (adjusted HR 1.46 (95% CI 1.04–2.05); p = .02; adjusted HR 1.80 (95% CI 1.23–2.61); p = .002; respectively). On-treatment sodium < LLN was significantly associated with progressive disease (OR 0.23 (95% CI 0.10–0.56); p = .001). A landmark analysis demonstrated that on-treatment hyponatremia was significantly associated with shorter OS and PFS (p = .01 and p = .03, respectively). On-treatment normalization of hyponatremia was associated with improved OS (unadjusted HR 0.61 (95% CI 0.35–0.98); p = .04), as compared to patients with sustained hyponatremia throughout follow-up. Conclusions: Hyponatremia associates with poor outcome in mRCC patients treated with everolimus. On-treatment normalization of hyponatremia to normal sodium values associates with favorable outcome.Keywords
This publication has 34 references indexed in Scilit:
- Hyponatremia, all-cause mortality, and risk of cancer diagnoses in the primary care setting: A large population studyEuropean Journal of Internal Medicine, 2016
- Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patientsBritish Journal of Cancer, 2015
- A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2Acta Oncologica, 2015
- Sunitinib‐induced hypertension, neutropaenia and thrombocytopaenia as predictors of good prognosis in patients with metastatic renal cell carcinomaBJU International, 2014
- Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinomaBritish Journal of Cancer, 2013
- Relationship of Serum Sodium Concentration to Mortality in a Wide Spectrum of Heart Failure Patients with Preserved and with Reduced Ejection Fraction: An Individual Patient Data Meta-AnalysisEuropean Journal of Heart Failure, 2012
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter StudyJournal of Clinical Oncology, 2009
- An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosisLiver Transplantation, 2007
- Hyponatremia in Community-Acquired PneumoniaAmerican Journal of Nephrology, 2007
- Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trialAcute Cardiac Care, 2007